OPEN END TURBO LONG - MERCK & CO. | Real-time Bid/Ask 10:17:49 2024-06-03 EDT | ||
| 4.72 EUR / 4.73 EUR | +5.70% |
|
| 1 month | -9.15% | ||
| 3 months | -6.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 4.46 | -0.22% |
| 24-05-31 | 4.47 | -3.87% |
| 24-05-30 | 4.65 | +2.65% |
| 24-05-29 | 4.53 | +0.89% |
| 24-05-28 | 4.49 | -6.46% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 09:09 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MA55AZ |
| ISIN | DE000MA55AZ1 |
| Date issued | 2021-03-16 |
| Strike | 77.29 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.24 € |
|---|---|
| Lowest since issue | 0.1 € |
| Spread | 0.01 € |
| Spread % | 0.21% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
